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Genentech Inc., South San Francisco, CaliforniaABSTRACT Small-angle neutron scattering (SANS) is used to probe the solution structure of two protein therapeutics (mono-
clonal antibodies 1 and 2 (MAb1 andMAb2)) and their protein-protein interaction (PPI) at high concentrations. These MAbs differ
by small sequence alterations in the complementarity-determining region but show very large differences in solution viscosity.
The analyses of SANS patterns as a function of different solution conditions suggest that the average intramolecular structure of
both MAbs in solution is not significantly altered over the studied protein concentrations and experimental conditions. Even
though a strong repulsive interaction is expected for both MAbs due to their net charges and low solvent ionic strength, analysis
of the SANS data shows that the effective PPI for MAb1 is dominated by a very strong attraction at small volume fraction that
becomes negligible at large concentrations. The MAb1 PPI cannot be modeled simply by a spherically symmetric central forces
model. It is proposed that an anisotropic attraction strongly affects the local interprotein structure and leads to an anomalously
large viscosity of concentrated MAb1 solutions. Conversely, MAb2 displays a repulsive interaction potential throughout the con-
centration series probed and a comparatively small solution viscosity.INTRODUCTIONTherapeutic monoclonal antibodies (MAbs) have been
found to be highly effective agents in the treatment of
immunological and allergic disorders, as well as malignant
growth (1–5), with a high level of success due to their struc-
tural specificity and low toxicity in contrast to many tradi-
tional small-molecule drug options (6,7). During the last
several decades, more than 20 MAbs have been approved
by the FDA for clinical use (7), and several hundred are
currently in development (8). Because of their success and
effectiveness, MAbs are one of the fastest growing therapeu-
tic agents on the market (6).
Currently, many therapeutic MAb products are often
administered in high doses, typically in the hundreds of mil-
ligrams (9,10), by an intravenous route at dilute conditions.
The pharmaceutical industry is now proposing the use of
subcutaneous (SC) injection delivery methods for some
MAbs due to the convenience (10) and reduced number/
frequency of administrations (9). However, SC delivery
imposes a constraint on the volume of MAb solution that
can be injected (~1.5 mL) (10). Thus, the high concentration
of MAbs (>50 mg/mL) often required to attain efficacious
dosages sometimes leads to nonideal solution behavior,
such as a large solution viscosity (11,12), which limits the
use of SC delivery (13). Recent experimental results suggest
that the increased viscosity (14–16) of concentrated MAb
protein solutions is related to the reversible or dissociable
aggregates/clusters that are dictated by the protein-proteinSubmitted November 13, 2012, and accepted for publication June 24, 2013.
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0006-3495/13/08/0720/12 $2.00interactions (PPIs) (13,14,16–18). Understanding the nature
of these PPIs as a function of protein concentration and
formulation procedure is thus very important and could
lead to more rational primary-structure design approaches
and/or selection of efficient excipient conditions for the
reduction of high-concentration MAb solution viscosities.
Numerous biophysical techniques, such as dynamic and
static light scattering (12,19), molecular modeling (20),
zeta potential (10,12), and rheological methods, have been
used to extract information about PPIs between MAbs in
solution (10,12,14,18,21–28). Here, we focus on two
MAbs (MAb1 and MAb2) that have been widely investi-
gated, as these two MAbs in solution show dramatically
different viscosity responses as a function of concentration
despite the small difference in their primary structure
(10,13,14,17–19,22,23,27–30). In particular, solutions of
MAb1 exhibit a very large viscosity increase with increasing
protein concentration compared to solutions ofMAb2. Based
on sedimentation equilibrium analysis of different concen-
trations of protein solutions, Liu et al. proposed that the elec-
trostatic charge interaction between MAb1 molecules may
be responsible for the large increase in viscosity as a function
of concentration (14). Kanai et al. studied Fab and Fc frag-
ments in a MAb protein and observed that Fab-Fab interac-
tions, in contrast to the Fab-Fc or Fc-Fc fragment
interactions, resulted in an increase in viscosity (18). Using
various bioanalytical techniques, it was confirmed that the
addition of salt decreases the viscosity in MAb1 as a result
of the screening effects (14). A recent calculation of the elec-
trostatic surface potential of MAb1 and MAb2 suggests that
the nonuniform charge distribution may affect the PPIhttp://dx.doi.org/10.1016/j.bpj.2013.06.043
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becomes important for understanding the PPI at large protein
concentrations. It is noted that the similar ionic strength
dependence of viscosity has been observed in other MAbs
as well (12). Thus, despite differences in primary structure
between some MAbs, a general understanding of one MAb
systemwill be helpful for understanding otherMAb systems.
Scattering methods have been shown to be successful in
probing PPIs in solutions of globular proteins (31–35).
Here we use small-angle neutron scattering (SANS) to study
MAb PPIs in concentrated solutions relevant for SC
delivery. SANS probes length scales commensurate with
the protein’s size and typical interparticle distance and, as
such, provides a detailed measurement of the conformation
and spatial arrangement of the macromolecules in solution.
As a result, SANS measurements provide information about
the conformation of individual proteins in solution, as well
as the PPIs of concentrated samples. Most studies on MAb
solutions using small-angle scattering have focused on the
study of the conformation of individual proteins at dilute
concentrations (36,37). Here, we directly probe PPIs at large
protein concentrations at various conditions and explore the
possible relation between the intermolecular MAb interac-
tion potential and the solution viscosity of the aforemen-
tioned two MAbs, MAb1 and MAb2 (10,27). Such SANS
studies can complement previous static light scattering mea-
surements of MAb PPIs at high concentrations and different
ionic strengths (38) by providing additional information
about the solution structure of the scattering species. In
addition, we investigate the possible conformation change
of MAbs due to a crowding effect at high concentrations
for different solution conditions (39).EXPERIMENTAL DETAILS
Materials
Two full-length humanized MAbs (which will be referred to
in this article as MAb1 and MAb2) were constructed at
Genentech (South San Francisco, CA). (Identification of
certain commercial equipment, instruments, or materials
in this document does not imply recommendation or
endorsement by the National Institute of Standards and
Technology, nor does it imply that the products identified
are necessarily the best available for the purpose.) The sub-
class of these two MAbs is human IgG1, which is expressed
in a Chinese hamster ovary cell line. The molecular weights
of MAb1 and MAb2 are 149 kDa and 148 kDa, respectively.
MAb1 and MAb2 have 92% sequence similarity and are
constructed with the same human IgG1 framework and k
light chain where the differences reside in the complemen-
tarity-determining region (CDR) and flanking amino acid
residues (30). Therefore, the charge distributions on these
two MAbs are the same except at the tip of the Fab domains
where the CDRs reside (29). All of the formulations in thisstudy are in 32 mM histidine/histidine-HCl buffer with
360 mM sucrose and 0.6 mg/mL polysorbate-20 at pH 6.0
(pDz 6.4) in D2O. To evaluate the impact of pH, a similar
buffer was used but titrated with HCl or NaOH to achieve a
desired pH (e.g., 5.5 or 6.5). The previously measured
charges of MAb1 and MAb2 at pH 6.0 via membrane-
confined electrophoresis are þ6.3 and þ11.9 (30), whereas
their theoretical charges areþ17 andþ27, respectively (19).
For stability purposes, lyophilized MAb samples and
their buffers were stored separately, protected from light,
at 4C until the actual small-angle scattering experiments.
For the SANS studies, both MAb1 and MAb2 were reconsti-
tuted in their respective D2O-based buffers. The D2O-based
buffer was used instead of the standard H2O-based buffer
because the D2O-based buffer has smaller incoherent back-
ground, thereby enhancing the coherent scattering intensity.Methods
The MAbs are reconstituted first to 150 mg/mL with their
appropriate buffers and allowed to mix into a homogenous
solution at 4C one day before the SANS experiments.
Additional protein concentrations (50 mg/mL and 100 mg/
mL) were prepared by diluting the concentrated samples
with the corresponding formulation buffers. The samples
at 5 mg/mL were prepared by diluting the most concentrated
sample (150 mg/mL) to 5 mg/mL with 50 mM NaCl in
D2O only.
All rotational shear data were acquired on a stress-rate-
controlled rheometer (Physica MCR 501, Anton Paar,
Graz, Austria) (40) using a 50 mm 0.490 anodized
aluminum cone geometry with the temperature set at 205
0.1C for all experiments. Since the rheology of protein dis-
persions are not known to be dependent on the loading proce-
dure, the cone was lowered to the desired gap (48 mm)
instantaneously. A flow sweep ascending and descending
from 1 s1 to 2000 s1 was performed to check for hysteresis
and sample degradation. MAb1 andMAb2 were measured at
5, 10, 20, 50, 100, and 150 mg/mL in their D2O buffers. All
sampleswere stable and reversiblewith negligible hysteresis.
The neutron-scattering data were collected on the NG-3
and NG-7 SANS beamlines at the NIST Center for Neutron
Research (Gaithersburg, MD). The raw data were reduced
and analyzed with the Igor Pro NCNR SANS software
according to standard methods (41).Theory
For a one-component system with spherical particles, the
measured SANS intensity, I(Q), can be represented as
IðQÞ ¼ fVpðDrÞ2PðQÞSðQÞ þ B; (1)
where B is the background, Vp and f are the volume of
one individual particle and the sample volume fraction,Biophysical Journal 105(3) 720–731
FIGURE 1 Relative viscosity of MAb1 (open circles) and MAb2 (open
squares) at zero shear frequency with the model fit. The solid lines are
the best fits to the experimental data based on the hard-sphere analysis rep-
resented by Eq. 4. The error bars are not shown, because they are smaller
than the symbols.
722 Yearley et al.respectively, and Dr is the scattering-length density dif-
ference between a particle and the solvent. Q ¼ 4p=
l sin q=2, where q is the scattering angle and l is the neutron
wavelength. P(Q) is the normalized intraparticle structure
factor (or normalized form factor). S(Q), the interparticle
structure factor, is the Fourier transformation of the correla-
tion of the center of mass of all particles in a solution, which
is sensitive to the interparticle potential (32,42,43). Thus, by
modeling S(Q), the interaction potential can be extracted
(31,35,44,45).
When a particle is not spherical, in the case of many non-
globular proteins, the above equation needs to be modified.
An estimate of I(Q) for a nonspherical particle using the
decoupling approximation (46,47) can be expressed as
IðQÞ ¼ fVpðDrÞ2PðQÞ~SðQÞ þ B; (2)
where P(Q) is the angular averaged form factor, and ~SðQÞ is
the apparent interparticle structure factor, which is linked to
the true interparticle structure factor, S(Q), using the decou-
pling approximation (32,46), as
~SðQÞ ¼ 1þ bðQÞðSðQÞ  1Þ
bðQÞ ¼ j<FðQÞ>j
2
<jFðQÞj2>;
(3)
where F(Q) is the Fourier transformation of the density dis-
tribution of an individual particle. Angled brackets indicate
the angular average of all possible orientations of a particle.
Note that<jF(Q)j2> is equal to P(Q). b(Q) only depends on
the molecular shape (and polydispersity) and is independent
of the interaction. The details of methods to calculate S(Q)
from an interaction potential are given in the Supporting
Material together with the discussions of the assumptions
used in obtaining Eq. 3.RESULTS AND DISCUSSION
The relative viscosities of MAb1 and MAb2 in D2O at a
series of concentrations are shown in Fig. 1. The viscosities
of both MAb1 and MAb2 at concentrations <50 mg/mL
approach the value of their solvent viscosity and primarily
reflect the incremental viscosity increase due to the presence
of individual MAbs in solution. At concentrations >50 mg/
mL, the viscosities of both MAb1 and MAb2 solutions
increase more rapidly with protein concentration. The vis-
cosity of the solution at these concentrations is increased
by MAb PPIs (14). Despite the nearly identical primary
structure (29), the MAb1 viscosity is significantly higher
than that of the MAb2, especially at high concentrations
(R100 mg/mL).
Following the literature, the relative viscosity data are
fitted using a form of the Maron-Pierce equation (48)
(Fig. 1):Biophysical Journal 105(3) 720–731hr ¼

1 C
Cmax
2
; (4)
where hr is the relative viscosity and C and Cmax are the
sample mass concentration and the maximum mass concen-
tration, respectively. The only fitting parameter is Cmax. The
original Maron-Pierce equation implements a volume frac-
tion, f, rather than mass concentration. Since it is difficult
to accurately estimate the effective volume fraction of a
MAb sample, the volume fraction is substituted for the
mass concentration. Fits to the data (up to 100 mg/mL for
MAb1) resulted in Cmax values of 119.0 5 0.1 mg/mL
and 205.6 5 1.3 mg/mL for MAb1 and MAb2 in the D2O
based buffer, respectively. Past studies have proposed that
the effective radius for these types of MAbs is ~4.4 nm
(19). Based on this number and assuming a spherical shape,
the effective maximum packing volume fraction,fmax, is
calculated to be z17% and z30% for MAb1 and MAb2,
respectively. Equation 4 adequately fits the MAb2 viscosity
trend at all examined concentrations, whereas the fitting of
the MAb1 is performed for concentrations at 100 mg/ml
and below. It has been speculated that the deviation of the
MAb1 protein from the rheological model is due to the
result of the combination of attractive and repulsive PPIs
for MAb1 in contrast to the mostly repulsive PPIs for
MAb2 (10). A further understanding of this deviation can
be gained by consideration of the PPIs measured by
SANS. Before presenting this, the scattering form factor
of MAbs at various conditions must be measured and under-
stood, as described in the next section.The effect of different experimental conditions on
intraprotein conformations
The form factor, P(Q), of a MAb protein is estimated with a
simple model to understand SANS patterns from MAbs in
solution (see Figs. S1 and S2 in the Supporting Material).
FIGURE 2 (a and b) PLS plots of MAb1 (a) and MAb2 (b), where the
blue squares, green diamonds, and red triangles are the results at protein
concentrations of 50 mg/mL, 100 mg/mL, and 150 mg/mL, respectively,
in a D2O-based buffer. (c) Comparison of the PLS plots of MAb1 (blue tri-
angles) and MAb2 (red triangles) at 150 mg/mL in a D2O-based buffer.
(d) Magnification of the plot in c to show the difference between the scat-
tering patterns.
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form factor, which greatly facilitates the analysis of MAb
scattering data. (The mathematical details of this model
are given in the Supporting Material.) To the best of our
knowledge, this is the first analytical model for this type
of scattering object.
This coarse-grained model approximates a MAb struc-
ture with three interconnected rectangular boxes (repre-
senting the two Fab and one Fc arms) and ignores
details of the amino acid sequence. The model represents
the effect on the scattering data of the relative arrange-
ment of different domains in a MAb protein. The effect
of the arrangement of these three domains on the form
factor is shown in Fig. S3. Through these model calcula-
tions, it is found by varying the relative positions (or an-
gles) of domains that the change of the form factor shape
is readily observed in the intermediate Q range
(0.02 A˚1 < Q < 0.2 A˚1), whereas the scattering pattern
remains relatively unchanged at very high Q (Q >
0.2 A˚1). This observation was anticipated and is consis-
tent with previously published experimental observations
(49). For large Q, the scattering pattern mainly reflects
the shape of the individual MAb domains, which are not
expected to change.
At higher concentrations, the apparent structure factor,
~SðQÞ, also contributes to the scattering patterns, yet it is
still possible to investigate the conformation change of
proteins directly from I(Q) by considering data at the inter-
mediate- and high-Q regimes. As shown in Fig. S4 b, the
interaction peak of ~SðQÞ is located around 0.06 A˚1 and
~SðQÞ becomes nearly 1 for Q > 0.1 A˚1. Hence, at high
protein concentrations, the scattering patterns at Q >
0.1 A˚1 still primarily reflect the form factor information.
Therefore, even at high MAb concentrations, the scattering
patterns are expected to be sensitive to the large change in
the intraprotein structure for 0.1 A˚1 < Q < 0.2 A˚1. We
will therefore use this Q range to investigate the possible
conformation change of a MAb protein in the high-concen-
tration region.
Because both the coherent scattering intensity and back-
ground (mostly due to incoherent scattering) change with
concentration, a Porod’s law scaling (PLS) analysis
method is proposed and conducted to compare the data
from different concentrations. (See the Supporting Material
for more information concerning the PLS method.) At
high Q values (i.e., >0.2 A˚1), the data were fitted with
the equation
IðQÞ ¼ AQ4 þ B; (5)
where B is the background (51). (Although rigorously
speaking, the Q values at 0.2 A˚1 are not really in the Porod
law region for a MAb protein, the theoretical form factor
still shows approximately a Q4 decay at Q > 0.2 A˚1.
Therefore, it is still valid to use the PLS analysis.) After ob-taining the values of A and B, the SANS data are plotted ac-
cording to the equation
ðIðQÞ  BÞ
A
: (6)
This modification to the scattering data eliminates the effects
of the background- and concentration-dependent terms,
except the concentration dependence arising from ~SðQÞ.
The resulting PLS plots of MAb1 and MAb2 at 50, 100,
and 150 mg/mL are shown in Fig. 2, a and b, respectively.
The scattering curves of both MAb1 and MAb2 at Q values
>0.1 A˚1 do not change as the concentration varies. As
demonstrated by Fig. S3, a large change of internal structure
should result in a variance of the form factor between 0.1
and 0.2 A˚1. Therefore, the experimental invariance of the
scattering data in this Q range indicates that the individual
MAb structures are not significantly altered when the con-
centration is increased. This is direct evidence that the intra-
protein conformation is concentration-invariant for these
MAb solutions for concentrations up to 150 mg/mL. It
should also be noted that computer simulations have shown
that proteins with a flexible hinge region are able to adopt
different structural conformations in solution (20). TheBiophysical Journal 105(3) 720–731
724 Yearley et al.above results can be interpreted to show that the statistically
averaged MAb structures remain relatively unaltered at high
concentrations.
Interestingly, differences in the intramolecular structures
of MAb1 and MAb2 appear to be distinguishable, as
observed from the superposition of the PLS plots of
MAb1 and MAb2 at 150 mg/mL (Fig. 2, c and d). This
difference in the intermediate Q region indicates that the
internal conformations of highly concentrated MAb1 and
MAb2 solutions are different from each other. It is conceiv-
able given the flexibility of MAbs (especially in the hinge
region) that their conformations are influenced by the local
interactions. The detailed analysis of the structural differ-
ence of these two MAbs is still ongoing.
The pH, sugar concentration, salt concentration, and sur-
factant concentration may also affect MAb structure. An
exploration of the effect on P(Q) was conducted by varying
these parameters (Fig. 3). SANS results of MAb1 at
different pH conditions, salt concentrations, and sugar and
surfactant conditions after a PLS analysis are shown in
Fig. 3, a–c, respectively. The data in the intermediate Q
range overlap with each other very well despite the change
of salt concentration, pH values, and sugar and surfactant
conditions. This indicates that the intramolecular solution
structure of MAb1 is not altered significantly in each case.
In the low-Q region, it is not surprising that pH and salt
concentration affect the SANS intensity indicating that the
change of the interactions between proteins is affected by
the solvent conditions.PPIs and their effect on viscosity
The invariance of P(Q) at different concentrations is very
important in extracting ~SðQÞ, through which the nature of
the PPIs can be illustrated. To separate the individual contri-
butions of the ~SðQÞ and P(Q) from the overall scattering
data (i.e., I(Q)), the conventional method requires that scat-
tering data be acquired from a dilute solution to extract
P(Q). At larger concentrations, ~SðQÞ is obtained by dividing
I(Q) by P(Q) from the dilute sample. This method can only
be applied if P(Q) is invariant at the investigated concentra-
tions. The PLS analysis method has demonstrated that theBiophysical Journal 105(3) 720–731conformations of our MAbs are essentially unchanged
within our concentration range. Thus, the same method
can be applied to obtain the apparent structure factor using
the data scaled by PLS analysis.
To understand the PPI, S(Q) can be calculated with statis-
tical mechanics theories. (Details are given in the Support-
ing Material.) Because of the anisotropic shape effect,
there are inevitably some anisotropic features in the PPI
between MAb proteins. But we will show that the calcula-
tion based on isotropic potentials can still help us reveal
the nature of the PPIs qualitatively. During the calculations,
we use the two-Yukawa potential (44) to model the PPI,
which can be expressed as
VðrÞ ¼
8><
>:
N; when
r
s
<1
K1eZ1ðr=s1Þ þ K2eZ2ðr=s1Þ; when r
s
R1
; (7)
where K1 and K2 are the strength of the attraction and the
repulsion part of the interaction. Z1 and Z2 are inversely pro-
portional to the interaction range of a potential, and s is the
diameter of the protein. The net attraction strength is equal
to K1  K2. To estimate the volume fraction of MAb sam-
ples, we have assumed the equivalent hard-sphere radius
of a MAb to be ~4.4 nm based on the results in Scherer
et al. (19). Therefore, s z 8.8 nm.
For spherical proteins, it is known that the PPI could have
both a short-range attraction and a screened Coulomb repul-
sion (31,44,52), which can be represented by the two-
Yukawa model shown in Eq. 7. The same model is used
here to understand the PPIs between MAbs. The Coulomb
repulsion between MAbs due to net charge should have a
Yukawa-type function form, and can be estimated based
on the known charge number and approximated ionic
strength using rescaling mean-spherical approximation
algorithm. The conventional DLVO theory is not used
here because rescaling mean-spherical approximation is
considered to be more accurate at large protein concentra-
tions, as it takes into consideration the correlation between
charged colloidal particles and coions/counterions in con-
centrated solutions (53). Regarding the attraction part of
the PPI, a Yukawa function form is used wherever anFIGURE 3 PLS plots of MAb1 at (a) 100 mg/
mL with different pH values (pD z pH þ 0.4);
(b) 150 mg/mL with different salt concentrations
in the buffer at pH 6.0 (pD ~6.4); and (c)
100 mg/mL with and without sugar molecules in
the buffer at pH 6.0 (pD ~6.4).
FIGURE 4 Experimental S(Qz 0) versus volume fraction (f) is shown
for MAb1 (black circles) and MAb2 (red squares) together with model cal-
culations for MAb2 only. The S(0) calculated by considering only charge
repulsion is shown as well. Calculations based on the theoretical charge
number and experimental charge number of MAb2 are represented by the
blue solid and green dashed lines.
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choices of the function forms for a short-range attraction
(31,44). Yet the choice of the function form is not expected
to affect our results. Also, it is known that the isotropic type
of attractive potential between proteins has typically a very
short interaction range whether its origin is due to van der
Waals interactions, hydrophobic interactions, or hydrogen
bonding (31,44,54). In our calculation, the short-range
attraction between proteins is assumed to be ~4 A˚ for
most cases, which is consistent with the interaction range
of the attraction between globular proteins (31,54). We
would also point out that even though we try to optimize
the parameters used for the calculations, some parameters
may be still slightly different from the true values. However,
these slight changes shall not affect our conclusions.
Even though we could only extract the apparent structure
factor, ~SðQÞ, from the experimental results, the difference
between ~SðQÞ and S(Q) is small at low-Q regions, as b(Q)
is almost one (see Fig. S4). We will mostly compare the
data in the low-Q region in this section.
PPI between MAb2 molecules
We first examine PPIs between MAb2 proteins, because
they are simpler than those of MAb1.
A MAb2 sample at 5 mg/mL was measured to obtain its
P(Q). The sample was prepared by diluting the samples
at 150 mg/mL with D2O to eliminate the scattering contribu-
tion from sugars and surfactants in a buffer. NaCl (50 mM)
was added to mitigate the long-range electrostatic repulsion
between MAbs. The SANS pattern is shown in Fig. S5 b.
The radius of gyration, Rg, was found to be 53.3 5
0.9 A˚, consistent with the literature result (55). ~SðQÞ and
S(0) were obtained using the rescaled data from the PLS
method to remove the effect of the contrast change between
proteins and solvent due to the change of the solvent from
the original buffer to essentially D2O.
The apparent structure factors of MAb2 at higher concen-
trations are presented in Fig. S6. In the high-Q region, the
values approach unity, as expected. The increasing error
bars at the high-Q region are due to the low scattering inten-
sity and relatively large background of the experimental
form factor measured at 5 mg/mL. Qualitatively, the
decreased value at low Q indicates the increased net repul-
sion when the concentration increases.
Experimental values of S(0) of MAb2 (Fig. 4, red
squares) as a function of volume fraction are obtained
from the ~SðQÞ as Q approaches zero, since ~Sð0Þ ¼ Sð0Þ.
As a comparison, the S(0) of MAb1 (Fig. 4, black circles)
is shown in the same figure, but will be discussed in
more detail later. Overall, S(0) of MAb2 is much smaller
than that of MAb1 at low concentrations. However, the
values of both MAbs become comparable at high concen-
trations. This dramatic difference in the concentration
dependence of S(0) indicates the large difference between
the PPIs in these two MAb samples.We compared the experimental S(0) of MAb2 with the
calculated S(0) by assuming that there is only charge
repulsion between proteins. Green dashed and blue solid
lines indicate the results calculated using the experimental
charge number (þ11.9) and the theoretical charge number
(þ30), respectively. As shown in Fig. 4, the results from
the experimental charge number are larger than the exper-
imental S(0) for all volume fractions, but have better
agreement at large volume fraction. On the other hand,
the results based on the theoretical charge number agree
with the experimental value at low volume fraction, but
are much smaller than those at large volume fractions.
Hence, the real charge number of MAb2 may be some-
where between the experimental charge number and the
theoretical charge number. If the effective charge number
could be better determined and the anisotropic effect could
be taken into consideration, the agreement could be better.
However, overall, this calculation based on isotropic
potentials shows that the PPI between MAb2 proteins
can be qualitatively described by the charge repulsion at
all concentrations.
Figs. S7 and S8 show the comparison between the exper-
imental ~SðQÞ and the calculated S(Q) at the same volume
fractions using the potentials discussed in Fig. 4. The esti-
mated volume fraction for the sample is ~0.072, 0.144,
and 0.216 at concentrations of 50 mg/mL, 100 mg/mL,
and 150 mg/mL, respectively. At 50 mg/mL, the calculated
S(Q) (shown in Fig. S8) based on the experimental charge
number is much larger than the experimental ~SðQÞ at the
Q values smaller than that of the first diffraction peak posi-
tion. This difference confirms the previous observation that
the charge repulsion of the PPI between MAb2 molecules isBiophysical Journal 105(3) 720–731
726 Yearley et al.stronger than that estimated from the experimental charge
number.
PPI between MAb1 molecules
In contrast toMAb2,where the PPI can be reasonably approx-
imated with a charge repulsion within the concentration
range studied, the results from MAb1 show completely
different features.
A sample of MAb1 at 5 mg/mL was prepared using the
same way as for the MAb2 sample. Its scattering pattern
is shown in Fig. S5 a (see the Supporting Material), with
Rg ¼ 66.45 0.7 A˚, much larger than the Rg of a monomer.
Further examination indicated that MAb1 can start forming
small amounts of reversible clusters at 5 mg/ml that give rise
to the increased Rg. These reversible clusters cannot be
filtered out during the sample preparation as they are due
to the PPI between MAb1 molecules. (The details of the
dynamic clustering effect will be addressed in a separate
publication.) Therefore, to estimate the S(0) of MAb1, we
have used the I(0) value of MAb2 protein at 5 mg/mL. As
the molecular mass of MAb1 is almost identical to that of
MAb2, this is accurate enough for the estimation of S(0)
for MAb1. However, we cannot use the measured form fac-
tor of MAb2 to extract the experimental S(Q) of MAb1,
since the form factors for MAb1 and MAb2 are different,
as shown in previous sections.
Fig. 5 a shows the extracted experimental S(0) of MAb1
at different concentrations together with the theoretical cal-
culations. The S(0) from MAb2 is also shown as a compar-FIGURE 5 (a) Experimental S(0) versus volume fraction (f) is shown for
MAb1 (black circles) and MAb2 (red squares) together with model calcu-
lations for MAb1 only. The blue solid and green dashed lines show the theo-
retical S(0) of MAb1 when the interaction potential only includes the
charge-repulsion effect. The blue solid line is based on the theoretical
charge number and the green dashed line on the experimental charge
number. The orange dash-dotted line is the S(0) for a hard-sphere system.
The solid pink line is the S(0) for a system with a charge repulsion (using
experimental charge number) and short-range attraction. The red dotted line
is similar to the pink solid line except that it is calculated using the theoret-
ical charge number to estimate the charge repulsion between proteins.
(b) The estimated net attraction strength for MAb1 using either the theoret-
ical charge number (black circles) or the experimental charge number (red
squares) is shown as a function of volume fraction. The net attraction
strength decreases dramatically when the concentration increases from
0.072 to 0.216.
Biophysical Journal 105(3) 720–731ison. We first calculated S(0) by considering only the charge
repulsion.
Different from the trend observed for MAb2, the results
based on both the theoretical charge number and the exper-
imental charge number (Fig. 5 a, blue solid line and green
dashed line, respectively) of MAb1 are all significantly
smaller than the experimental S(0) at f z 0.072 (50 mg/
mL). This discrepancy is so large that the difference cannot
be reconciled by the uncertainty of the charge number.
Actually, even if there is no charge, the estimated S(0)
(Fig. 6 a, orange dash-dotted line) is still much smaller
than the experimental S(0). Therefore, the comparison of
S(0) at fz 0.072 indicates that a strong attraction between
MAb1 proteins has to exist at small protein concentrations.
However, using the same potential, a progressively better
agreement is observed at large concentrations. In particular,
the results based on the experimental charge number show a
reasonable agreement with the experimental S(0) at f z
0.216 (150 mg/mL). By making the charge number smaller,
the calculated S(0) moves closer to the experimental S(0). If
there is no charge (Fig. 6 a, orange dash-dotted line), the
difference at f z 0.216 is so small that the small discrep-
ancy can be due to either the anisotropic interaction effect
or the existence of a weak attraction.
To estimate the effect of the attraction, we have further
estimated the attraction strength of the short-range attraction
that is needed to have an agreement between the calculated
S(0) and the experimental S(0) at fz 0.072. The estimated
net attraction is ~4.7 kBT when the theoretical charge num-
ber is used and ~3.6 kBT when the experimental charge is
considered. Therefore, the net attraction strength is some-
where between 3.6 kBT and 4.7 kBT at f z 0.072, which
is fairly strong between proteins in solution. As a com-
parison with a globular protein with known strong attrac-
tion, the net attraction strength between lysozymes in
water is ~2.7 kBT (56). The estimation of S(0) using the
same set of potential parameters is calculated at larger
volume fractions, shown as the pink solid and red dotted
lines in Fig. 5 a, corresponding to calculations using the
experimental charge number and the theoretical charge
number, respectively. Note that the results of the red
dotted line at very large volume fractions are not shown in
the figure, because the calculated S(0) is > 1.4. Clearly,
the attraction strength estimated at f z 0.072 is too large
at larger concentrations, as the predicted results show a
much larger value. Therefore, the attraction strength has to
be much smaller at large protein concentrations and strongly
dependent on the volume fraction.
The net attraction strength can be approximately esti-
mated at different volume fractions by fitting the experi-
mental S(0). The results are shown in Fig. 5 b. The black
circles and red squares indicate the results estimated using
the theoretical charge and experimental charge, respec-
tively. Because the anisotropic effect is not considered
here, the estimated number may not be very accurate.
FIGURE 6 (a) S(Q) for MAb1 calculated using the experimental charge
number is shown together with the experimental ~SðQÞ of MAb1. The esti-
mated volume fraction for 50 mg/mL, 100 mg/mL, and 150 mg/mL is
0.072, 0.144, and 0.216. (b) Calculated S(Q) for MAb1 is shown consid-
ering both a charge repulsion and short-range attraction corresponding to
the pink solid line in a. (c) S(Q) at 0.072 is shown as a function of the range
of the attraction while S(0) is forced to be the same by changing the short-
range attraction. (See text for details.)
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strength. Overall, the net attraction strength decreases
dramatically as a function of concentration. When the theo-
retical charge number (þ17) is used, the net attraction
strength decreases from 4.7 kBT at f z 0.072 to ~2.8 kBT
at f z 0.216. For the experimental charge case, the net
attraction strength changes from ~3.6 kBT at f z 0.072 to
~1.2 kBT at f z 0.216. Therefore, for MAb1 proteins, the
effective attraction strongly depends on its concentration
no matter which charge number is used. If the experimental
charge number can be considered to be a good approxima-
tion of the real charge number, the estimated net attraction
strength based on the experimental charge number becomes
very small at 150 mg/mL (fz 0.216), indicating that there
is only a weak attraction between MAb1s at this concentra-
tion. The overall PPI between MAb1 molecules changes
from a strongly attractive potential (3.6 kBT) at low concen-
trations to a weak attractive potential (1.2 kBT) at large con-
centrations. The combined effect of both the weak attraction
and the charge repulsion makes the calculated S(0) close to
the S(0) of a hard-sphere system (no charge repulsion and
no attraction). Therefore, the overall effective PPI after
combining the effect from both the attraction and the charge
repulsion is negligibly small at large concentrations com-
pared to the effect of the strong attractive PPI at low volume
fractions.
The consequence of this strong volume-fraction depen-
dence of the attraction means that great care is required
when studying MAb1 proteins at large concentrations based
on the pairwise potential obtained from dilute concentra-
tions. It is thus critical to directly examine the interaction
between MAb1 molecules at different concentrations.
To understand the reasons for this strong volume-fraction
dependence of the attraction between MAb1s, we have
further carefully compared the calculated S(Q) with the
experimental ~SðQÞ, as shown in Fig. 6. To obtain ~SðQÞ,
we used the rescaled I(Q) at 5 mg/mL of MAb1 using the
PLS method despite the presence of a small amount of
dynamic clusters already at this concentration. We believe
that this is still a reasonable approach, as the scattering
patterns from samples at smaller concentrations, such as
1 mg/mL, are too noisy at the intermediate- and high-Q
range to allow us to apply the PLS method. However,
without the PLS plot, we could not remove the contrast-
difference effect due to the change of solvent to D2O for
the sample at small concentrations. We feel that the obtained
S(Q) is accurate enough as long as the conclusions are only
drawn based on qualitative analyses.
During the following calculations, only the experimental
charge number is used as an example. All the conclusions
are the same if the theoretical charge number is used.
Fig. 6 a shows the comparison when only the charge
repulsion between MAb1s is considered. At 100 mg/mL
and 150 mg/mL, the shape of the theoretical S(Q) and the
experimental ~SðQÞ show a qualitatively similar trend.However, at 50 mg/mL, not only is S(0) significantly
different, but the shape of S(Q) at low Q values shows a
different trend. This is because the effect of the attraction
is not considered yet.
The corresponding S(Q) (black solid line) by adding
attractions is shown in Fig. 6 b. Even though the calculatedBiophysical Journal 105(3) 720–731
728 Yearley et al.S(0) agrees with the experimental S(0), the actual shape is
far from even a qualitative agreement between black solid
line and black solid circles. To better reproduce the low-Q
upturn, we fixed the charge repulsion and explored the effect
of the attraction range. During the calculations, we forced
S(0) to be the same at low Q. In Fig. 6 c, S(Q) is calculated
with different effective attraction ranges to be ~0.4 nm,
2.4 nm, and 4 nm. When the attraction range is increased,
the low-Q upturn is shifted to a lowerQ value. The attraction
range of 2.4 nm is still not large enough to reproduce the
low-Q upturn. The result at the attraction range of 4 nm
seems to reproduce the low-Q upturn shape nicely. There-
fore, it is reasonable to believe that the interaction range
of the attraction is relatively long, on the order of
~2–4 nm. A theoretical estimation shows that the low-Q up-
turn will be shifted to an even smaller Q value, resulting in
an even longer range for the attraction if a more accurate
form factor of MAb1 can be used. It is known that isotropic
attraction, whether it is due to van der Waals potential, hy-
drophobic effect, or hydrogen bonding, has a typically short
range (a few angstroms) for proteins. The possibly long-
range attraction may be due to the electric multipole effect,
such as electric dipole, resulted from the nonuniform charge
distribution on a protein surface.
Our hypothesis of charge-induced anisotropic attraction
is actually consistent with the published results of the sec-
ond virial coefficient, A2, as a function of the ionic strength
for MAb1. It has been shown that the A2 of MAb1 has a
negative value at small ionic strength and monotonically
increases when the ionic strength is increased (19). There-
fore, increasing the ionic strength makes the attraction be-
tween MAb1s smaller, indicating that the origin of the
attraction is mainly due to the charge-interaction effect,
which is pertinently linked to the charge distribution on
the protein surface. Actually, a recent electrostatic-potential
surface calculation shows that the charge distribution on a
protein surface is more heterogeneous on MAb1 than on
MAb2 (30). A coarse-grained computer simulation also in-
dicates that there could be charge-induced anisotropic inter-
action leading to the formation of a loose network in MAb1
solutions (29). Here, we provide strong experimental evi-
dence, based on SANS results, that the attraction between
MAb1s is indeed highly anisotropic, which is consistent
with the nonuniform surface charge distribution. It is noted
that the charge-induced anisotropic interaction has also been
shown to be important for the aggregation/disaggregation of
native proteins in solution (57).
The existence of this charge-induced anisotropic attrac-
tion is also fully consistent with the observed volume frac-
tion dependence of S(0) for MAb1 shown in Fig. 5 a. At
relatively low concentrations, there is enough space for mol-
ecules to take certain orientations to maximize the attractive
interaction. Therefore, the MAbs can achieve energetically
favorable pairwise orientations (e.g., Fab-Fab or Fab-Fc
types of interaction) whose populations are dictated by theBiophysical Journal 105(3) 720–731Boltzmann distribution, eVðrÞ=kBT . If the pairwise attrac-
tions are strong enough, this could lead to the formation
of dissociable/dynamic clusters with a finite lifetime.
Hence, the effective potential is dominated by attraction at
small volume fractions. However, when the concentration
is very high, the MAb molecules are forced to pack so
tightly that there is not enough space to allow all MAb
molecules to simultaneously achieve the most energetically
favored pairwise interaction with all neighboring particles.
The attraction between two molecules with the correct ori-
entations may not change significantly when the concentra-
tion changes. However, there will be more molecules around
one reference molecule that feel mostly repulsion from the
reference molecule due to the charge repulsion. The average
interaction potential between the reference molecule and the
surrounding molecules becomes less attractive when the
concentration increases. Thus, due to these many body inter-
actions, where a molecule’s interaction potential with its
neighbor molecule depends on the configurations of other
molecules surrounding them, the average (or effective) pair-
wise potential can change from an overall attractive poten-
tial to a weakly attractive potential, as manifested by the
change in compressibility, S(0). Hence, the observed
decrease of S(0) as a function of concentration is expected.
In contrast, the PPI between MAb2 molecules is domi-
nated by overall repulsive interaction throughout the con-
centration range. These differences in interaction potential
between MAb1 and MAb2 thus dramatically affect their
interprotein structure and macroscopic properties such as
viscosity. The increased viscosity of MAb1 results from a
local anisotropic attraction that may cause the formation
of dynamic clusters or local ordering. This local ordering
could lead to a larger effective excluded volume that causes
the significant increase in viscosity. Because the effective
PPI between MAb1s changes dramatically as a function of
concentration, the contribution to the viscosity may be due
to different features of the potential at different concentra-
tions. Therefore, it is not surprising that MAb1 viscosity
cannot be fitted reasonably with a simple hard-sphere anal-
ysis, whereas the same equation seems to reasonably explain
the behavior of MAb2 viscosity. Thus, the difference of the
potential dependence as a function of concentration qualita-
tively explains the viscosity difference between MAb1 and
MAb2.
We point out that the effective potential of interaction
between colloidal particles such as proteins is generally
quantitatively dependent on the volume fraction, as the pair-
wise potential usually contains contributions from the
coions, counterions, solvent molecules, and other small
molecules in buffer, which are affected by concentration
(58). However, the change of effective PPI between
MAb1s is so large that the solvent molecule effect itself
could not explain this concentration dependence. The key
factor is the anisotropic attractive interaction potential due
to the heterogeneous charge distribution on protein surface.
SANS Study of MAb Conformations and PPIs at High Concentrations 729The pairwise potential for MAb1 is observed to change from
a strong attractive potential at a low concentration to a
potential with a negligible attraction effect at large con-
centrations. Such a large change of the effective pairwise
interaction by simply increasing protein concentration has
not been observed in any spherical protein systems to the
best of our knowledge. Actually, many studies have
shown that the pairwise potential does not change much in
many globular protein systems, sometimes even in the
case of nonspherical proteins such as MAb2 in this study
(31,34,54,56,59–61).CONCLUSION
IgG1 MAbs have been probed in this study to examine the
interactions between proteins in concentrated solutions
using SANS. To understand the SANS scattering pattern
quantitatively, an analytical form factor for a three-arm
model representing the two Fab arms and the Fc arm of a
MAb has been developed for the first time, to our knowl-
edge. The change of the form factor is analyzed when the
relative positions of different arms are altered. Aided by
this analytical model, it is found that in the intermediate-
Q range, the SANS data are sensitive to the variation of
MAb conformation changes for the scattering patterns
from concentrated solutions.
The intramolecular structure as a function of concentra-
tion is studied by the proposed PLS method. The analyses
of SANS data show that the conformations of neither
MAb1 nor MAb2 proteins change significantly as a function
of concentration from 50 to 150 mg/mL. Furthermore, the
PLS analysis suggests that for MAb1 at concentrations of
100 and 150 mg/mL, no substantial conformation changes
occur within the studied experimental conditions (pH 5.5–
6.5, NaCl from 0 to 150 mM, and with or without
360 mM sugar).This suggests that for these MAbs at these
high concentrations (>100 mg/mL) and conditions, the
crowded environment has little effect on the intramolecular
structure despite the inherent flexibility of MAbs (i.e., due to
the hinge region).
The observation of the invariance of the form factor of our
MAb proteins at different concentrations is an interesting
result, suggesting minimal changes in MAb conformation
due to crowding effects. It also makes possible the extrac-
tion of the apparent interparticle structure factor by dividing
I(Q) by P(Q), obtained at the dilute condition. The effect to
the apparent structure factor due to the anisotropic protein
shape was estimated. It was concluded that at low Q values,
the apparent interparticle structure factor can be a reason-
able approximation of the true interparticle structure factor,
which contains the important information about the PPI.
The investigation of samples at large concentration using
SANS enables us to understand the interparticle potential
between MAb proteins. By analyzing the volume fraction
dependence of the compressibility (S(0)) of MAb1 andMAb2, it was found that the PPIs between MAb1s change
dramatically from a strongly attractive potential at small
volume fractions to a potential with negligible attraction
at large concentrations. However, the PPI between
MAb2s is mostly dominated by charge repulsion in the
concentration range studied. Taking together our SANS
results and the literature information, we propose that the
attractive PPI between MAB1s is highly anisotropic and
is induced by the heterogeneous charge distribution on a
protein surface. This hypothesis of the highly anisotropic
attraction among MAb1s can fully explain the volume-
fraction dependence of S(0) at all volume fractions. The
existence of this strong anisotropic attraction between
MAb1s could lead to the formation of dynamic clusters
that could cause a large increase in viscosity of the MAb
systems. Thus, the strong anisotropic attraction is believed
to be the reason for the increased viscosity in MAb1 solu-
tions. On the other hand, because PPIs between MAb2s are
dominated by charge repulsion, the system is mostly domi-
nated by monomers. Therefore, its viscosity has a weak
concentration dependence compared with that of MAb1.SUPPORTING MATERIAL
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